View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/CMS | RIN: 0938-AP64 | Publication ID: Spring 2011 |
| Title: Medicare Advantage and Prescription Drug Benefit Programs; Payments to Sponsors of Retiree Prescription Drug Plans (CMS-4131-F2) | |
| Abstract: This rule will specify whether Retiree Drug Subsidy plan sponsors can continue to choose to report either the "pass-through price" or the "lock-in price" when reporting Part D drug cost data. | |
| Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
| Major: No | Unfunded Mandates: No |
| CFR Citation: 42 CFR 422 and 423 | |
| Legal Authority: 42 USC 1302 42 USC 1395w-101 to 1395w-152 42 USC 1395hh | |
Legal Deadline:
|
||||||||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
| Small Entities Affected: Businesses | Federalism: No |
| Included in the Regulatory Plan: No | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: David Mlawsky Health Insurance Specialist Department of Health and Human Services Centers for Medicare & Medicaid Services Mail Stop C1-22-06, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-6851 Email: david.mlawsky@cms.hhs.gov |
|
An official website of the United States government



